当前位置: X-MOL 学术Arthritis Rheumatol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Povetacicept,一种增强型双重 APRIL/BAFF 拮抗剂,可调节 B 淋巴细胞和致病性自身抗体,用于治疗狼疮和其他 B 细胞相关的自身免疫性疾病
Arthritis & Rheumatology ( IF 11.4 ) Pub Date : 2023-01-27 , DOI: 10.1002/art.42462
Lawrence S Evans 1 , Katherine E Lewis 1 , Daniel DeMonte 1 , Janhavi G Bhandari 1 , Logan B Garrett 1 , Joseph L Kuijper 1 , Daniel Ardourel 1 , Martin F Wolfson 1 , Susan Debrot 1 , Sherri Mudri 1 , Kayla Kleist 1 , Luana L Griffin 1 , LuAnne Hebb 1 , Russell J Sanderson 1 , NingXin Wang 1 , Michelle Seaberg 1 , Allison G Chunyk 1 , Jing Yang 1 , Youji Hong 1 , Zahra Maria 1 , David J Messenheimer 1 , Pamela M Holland 1 , Stanford L Peng 1 , Mark W Rixon 1 , Stacey R Dillon 1
Affiliation  

APRIL/BAFF 信号失调与多种自身免疫性疾病的发病机制有关,包括系统性红斑狼疮和狼疮性肾炎。我们开展这项研究是为了开发和评估高亲和力 APRIL/BAFF 拮抗剂,以克服现有 B 细胞抑制剂的临床局限性。



"点击查看英文标题和摘要"

更新日期:2023-01-27
down
wechat
bug